Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the tandardized collection of a minimum set of data
Abstract Background and objective: The objective of this study was to reach a consensus on the minimum set of data that would allow to optimize the pharmacotherapy follow-up of patients on biologic agents for chronic systemic inflammatory conditions, through structured and standardized collection with an electronic tool in the hospital pharmacy. Materials and method: A scientific committee was formed (n = 5 hospital pharmacists). The Delphi Technique was used, 2 rounds of consultation by e-mail for hospital pharmacists. A structured questionnaire was used, based on a bibliographic review and recommendations by the scientific committee; 37 statements were assessed with the Likert 5-point scale (1= “Strongly Disagree”; 5= “Strongly Agree”). Consensus was reached when 75% or more of panel members assigned a score of 1-2 (rejection consensus) or 4-5 (agreement consensus) to the matter reviewed. Descriptive statistical analyses were conducted. Results: The study included 21 hospital pharmacists (70 were invited, there was 70% response). Consensus was reached for 100% of statements. The minimum set of data was agreed upon, as well as the recommendations that the pharmacist had to collect and make during visits: to document the health status, health-related quality of life, changes in treatment compliance and in patient autonomy, as well as the conditions to make feasible the systematic collection of the minimum data set. Conclusions: There is consensus among hospital pharmacists about a minimum data set to be collected, through an electronic tool, which will order, standardize and structure the pharmacotherapy follow-up of patients with chronic inflammatory conditions on treatment with biologic agents in the Spanish public health system.
Main Authors: | , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Grupo Aula Médica
2017
|
Online Access: | http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-63432017000100031 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S1130-63432017000100031 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S1130-634320170001000312020-10-22Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the tandardized collection of a minimum set of dataCalleja Hernández,Miguel ÁngelHerrero Ambrosio,AliciaLamas Díaz,María JesúsMartínez Cutillas,JulioPoveda Andrés,José LuisAragón,Belén Pharmacotherapy follow-up Hospital pharmacy unit Systemic inflammatory condition Tumour necrosis factor-alpha Consensus Delphi Abstract Background and objective: The objective of this study was to reach a consensus on the minimum set of data that would allow to optimize the pharmacotherapy follow-up of patients on biologic agents for chronic systemic inflammatory conditions, through structured and standardized collection with an electronic tool in the hospital pharmacy. Materials and method: A scientific committee was formed (n = 5 hospital pharmacists). The Delphi Technique was used, 2 rounds of consultation by e-mail for hospital pharmacists. A structured questionnaire was used, based on a bibliographic review and recommendations by the scientific committee; 37 statements were assessed with the Likert 5-point scale (1= “Strongly Disagree”; 5= “Strongly Agree”). Consensus was reached when 75% or more of panel members assigned a score of 1-2 (rejection consensus) or 4-5 (agreement consensus) to the matter reviewed. Descriptive statistical analyses were conducted. Results: The study included 21 hospital pharmacists (70 were invited, there was 70% response). Consensus was reached for 100% of statements. The minimum set of data was agreed upon, as well as the recommendations that the pharmacist had to collect and make during visits: to document the health status, health-related quality of life, changes in treatment compliance and in patient autonomy, as well as the conditions to make feasible the systematic collection of the minimum data set. Conclusions: There is consensus among hospital pharmacists about a minimum data set to be collected, through an electronic tool, which will order, standardize and structure the pharmacotherapy follow-up of patients with chronic inflammatory conditions on treatment with biologic agents in the Spanish public health system.Grupo Aula MédicaFarmacia Hospitalaria v.41 n.1 20172017-02-01journal articletext/htmlhttp://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-63432017000100031en |
institution |
SCIELO |
collection |
OJS |
country |
España |
countrycode |
ES |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-es |
tag |
revista |
region |
Europa del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Calleja Hernández,Miguel Ángel Herrero Ambrosio,Alicia Lamas Díaz,María Jesús Martínez Cutillas,Julio Poveda Andrés,José Luis Aragón,Belén |
spellingShingle |
Calleja Hernández,Miguel Ángel Herrero Ambrosio,Alicia Lamas Díaz,María Jesús Martínez Cutillas,Julio Poveda Andrés,José Luis Aragón,Belén Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the tandardized collection of a minimum set of data |
author_facet |
Calleja Hernández,Miguel Ángel Herrero Ambrosio,Alicia Lamas Díaz,María Jesús Martínez Cutillas,Julio Poveda Andrés,José Luis Aragón,Belén |
author_sort |
Calleja Hernández,Miguel Ángel |
title |
Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the tandardized collection of a minimum set of data |
title_short |
Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the tandardized collection of a minimum set of data |
title_full |
Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the tandardized collection of a minimum set of data |
title_fullStr |
Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the tandardized collection of a minimum set of data |
title_full_unstemmed |
Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the tandardized collection of a minimum set of data |
title_sort |
pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the tandardized collection of a minimum set of data |
description |
Abstract Background and objective: The objective of this study was to reach a consensus on the minimum set of data that would allow to optimize the pharmacotherapy follow-up of patients on biologic agents for chronic systemic inflammatory conditions, through structured and standardized collection with an electronic tool in the hospital pharmacy. Materials and method: A scientific committee was formed (n = 5 hospital pharmacists). The Delphi Technique was used, 2 rounds of consultation by e-mail for hospital pharmacists. A structured questionnaire was used, based on a bibliographic review and recommendations by the scientific committee; 37 statements were assessed with the Likert 5-point scale (1= “Strongly Disagree”; 5= “Strongly Agree”). Consensus was reached when 75% or more of panel members assigned a score of 1-2 (rejection consensus) or 4-5 (agreement consensus) to the matter reviewed. Descriptive statistical analyses were conducted. Results: The study included 21 hospital pharmacists (70 were invited, there was 70% response). Consensus was reached for 100% of statements. The minimum set of data was agreed upon, as well as the recommendations that the pharmacist had to collect and make during visits: to document the health status, health-related quality of life, changes in treatment compliance and in patient autonomy, as well as the conditions to make feasible the systematic collection of the minimum data set. Conclusions: There is consensus among hospital pharmacists about a minimum data set to be collected, through an electronic tool, which will order, standardize and structure the pharmacotherapy follow-up of patients with chronic inflammatory conditions on treatment with biologic agents in the Spanish public health system. |
publisher |
Grupo Aula Médica |
publishDate |
2017 |
url |
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-63432017000100031 |
work_keys_str_mv |
AT callejahernandezmiguelangel pharmacotherapyfollowupofpatientsundertreatmentwithbiologicagentsforchronicinflammatorysystemicconditionsanagreementamonghospitalpharmacistsforthetandardizedcollectionofaminimumsetofdata AT herreroambrosioalicia pharmacotherapyfollowupofpatientsundertreatmentwithbiologicagentsforchronicinflammatorysystemicconditionsanagreementamonghospitalpharmacistsforthetandardizedcollectionofaminimumsetofdata AT lamasdiazmariajesus pharmacotherapyfollowupofpatientsundertreatmentwithbiologicagentsforchronicinflammatorysystemicconditionsanagreementamonghospitalpharmacistsforthetandardizedcollectionofaminimumsetofdata AT martinezcutillasjulio pharmacotherapyfollowupofpatientsundertreatmentwithbiologicagentsforchronicinflammatorysystemicconditionsanagreementamonghospitalpharmacistsforthetandardizedcollectionofaminimumsetofdata AT povedaandresjoseluis pharmacotherapyfollowupofpatientsundertreatmentwithbiologicagentsforchronicinflammatorysystemicconditionsanagreementamonghospitalpharmacistsforthetandardizedcollectionofaminimumsetofdata AT aragonbelen pharmacotherapyfollowupofpatientsundertreatmentwithbiologicagentsforchronicinflammatorysystemicconditionsanagreementamonghospitalpharmacistsforthetandardizedcollectionofaminimumsetofdata |
_version_ |
1755939079411728384 |